Yahoo Web Search

Search results

    • Tempus launches new HER2 and FOLR1 testing solutions

      Tempus launches new HER2 and FOLR1 testing solutions

      Medical Device Network via Yahoo Finance· 5 days ago

      It can also be ordered for other cancer types at the clinician’s discretion. Tempus noted that FOLR1 testing is recommended for patients, who have...